Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,346.00
Bid: 12,376.00
Ask: 12,380.00
Change: 156.00 (1.28%)
Spread: 4.00 (0.032%)
Open: 12,304.00
High: 12,380.00
Low: 12,088.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Cuts Travis Perkins To Underweight

Thu, 11th Aug 2016 08:35

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
BARCLAYS CUTS TRAVIS PERKINS TO 'UNDERWEIGHT' ('EQUALWEIGHT') - TARGET 1400 (1950) PENCE
----------
LIBERUM ADDS BRITISH LAND TO 'CONVICTION SELL LIST'
----------
COMMERZBANK CUTS EASYJET PRICE TARGET TO 1200 (1350) PENCE - 'HOLD'
----------
JPMORGAN CUTS RBS PRICE TARGET TO 175 (185) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS LLOYDS PRICE TARGET TO 62 (65) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BARCLAYS PRICE TARGET TO 175 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ROLLS ROYCE GROUP PRICE TARGET TO 835 (730) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES PEARSON PRICE TARGET TO 935 (905) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES BHP BILLITON PRICE TARGET TO 900 (885) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1378 (1324) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 5600 (5400) PENCE - 'BUY'
----------
HSBC CUTS ASTRAZENECA PRICE TARGET TO 4700 (4815) PENCE - 'HOLD'
----------
FTSE 250
----------
LIBERUM REMOVES TULLOW OIL FROM 'CONVICTION SELL LIST'
----------
PANMURE CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 168 (145) PENCE
----------
RBC CAPITAL RAISES CENTAMIN PRICE TARGET TO 190 (170) PENCE - 'SECTOR PERFORM'
----------
Numis Ups Centamin Target To 180p From 160p, Keeps Hold
----------
HSBC RAISES SEGRO PRICE TARGET TO 418 (378) PENCE - 'HOLD'
----------
HSBC CUTS BRITVIC PRICE TARGET TO 620 (640) PENCE - 'HOLD'
----------
Investec Ups Virgin Money Target To 375p From 360p, Keeps Buy
----------
Cantor Cuts Debenhams Target To 60p From 70p, Keeps Hold
----------
Liberum Ups Spirax-Sarco Target To 4,090p From 3,140p, Keeps Hold
----------
MORGAN STANLEY RAISES SPIRAX-SARCO TARGET TO 4080 (3570) PENCE - 'EQUAL-WEIGHT'
----------
S&P GLOBAL RAISES AMEC PRICE TARGET TO 600 (500) PENCE - 'BUY'
----------
TRADERS: CANACCORD CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY')
----------
BERENBERG RAISES INMARSAT PRICE TARGET TO 910 (880) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
RBC CAPITAL CUTS FAROE PETROLEUM PRICE TARGET TO 100 (120) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES INTERSERVE PRICE TARGET TO 425 (416) PENCE - 'OVERWEIGHT'
----------
finnCap Initiates Joules Group With Buy, Target At 200p
----------
Berenberg Ups Benchmark Holdings Target To 80p From 70p, Keeps Buy
----------
BERENBERG RAISES STOCK SPIRITS PRICE TARGET TO 150 (137) PENCE - 'HOLD'
----------
BERENBERG CUTS LOOKERS PRICE TARGET TO 170 (220) PENCE - 'BUY'
----------
BERENBERG RAISES GVC HOLDING PRICE TARGET TO 760 (730) PENCE - 'BUY'
----------
BERENBERG RAISES STAFFLINE TO 'BUY' ('HOLD') - TARGET 1250 (900) PENCE
----------
Numis Ups Breedon Aggregates to Add From Hold, Target To 82p From 70p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more
3 Nov 2023 17:06

AstraZeneca plans next phase of trial on kidney drug combination data

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.

Read more
3 Nov 2023 11:34

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.

Read more
2 Nov 2023 15:57

UK earnings, trading statements calendar - next 7 days

Friday 3 November 
no events scheduled 
Monday 6 November 
Kingspan Group PLCTrading Statement
Kosmos Energy LtdQ3 Results
Ryanair Holdings PLCHalf Year Results
Tuesday 7 November 
Associated British Foods PLCFull Year Results
Beazley PLCQ3 Results
Direct Line Insurance Group PLCTrading Statement
dotdigital Group PLCFull Year Results
IWG PLCQ3 Results
Persimmon PLCTrading Statement
RS Group PLCHalf Year Results
Vaalco Energy IncQ3 Results
Watches of Switzerland Group PLCTrading Statement
Wednesday 8 November 
Conduit Holdings LtdQ3 Results
ITV PLCTrading Statement
JD Wetherspoon PLCQ1 Results
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Secure Trust Bank PLCTrading Statement
Smiths News PLCFull Year Results
Time Out Group PLCFull Year Results
Thursday 9 November 
3i Group PLCHalf Year Results
Apax Global Alpha LtdQ3 Results
AstraZeneca PLCQ3 Results
Auto Trader Group PLCHalf Year Results
B&M European Value Retail SAHalf Year Results
Domino's Pizza Group PLCTrading Statement
Endeavour Mining PLCQ3 Results
Flutter Entertainment PLCTrading Statement
IMI PLCTrading Statement
Indivior PLCQ3 Results
John Wood Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
National Grid PLCHalf Year Results
Regional REIT LtdTrading Statement
Renewi PLCHalf Year Results
S4 Capital PLCTrading Statement
Tate & Lyle PLCHalf Year Results
Taylor Wimpey PLCTrading Statement
TBC Bank Group PLCQ3 Results
TheWorks.co.uk PLCTrading Statement
Trakm8 Holdings PLCHalf Year Results
Urban Logistics REIT PLCHalf Year Results
Vistry Group PLCTrading Statement
WH Smith PLCFull Year Results
Wincanton PLCHalf Year Results
Wizz Air Holdings PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Nov 2023 08:59

AstraZeneca launches collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.

Read more
1 Nov 2023 07:33

AstraZeneca invests $220m in French gene-editing group Cellectis

(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.

Read more
30 Oct 2023 09:40

LONDON BROKER RATINGS: Jefferies cuts NatWest to underperform from buy

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
25 Oct 2023 11:04

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.